Page 48 - Multiple Sclerosis News Today

Sustained efficacy was confirmed with an annualized relapse rate of 0.098 and 67% of patients were relapse-free at six years Safety was consistent with prior findings and the established safety...

Immunic Inc (NASDAQ:IMUX) announced that it will present data from its Phase 2 CALLIPER and CALVID-1 clinical trials of its lead asset vidofludimus calcium...

We all know that soda is health-damaging due to sugars, but it doesn't end there. Here’s what’s really in Coca-Cola's famous Coke soda:

Young people could be spared from going blind by a new genetic risk tool that could also help diagnose multiple sclerosis (MS) earlier, to start effective treatments.

Ocrelizumab is currently the only approved treatment for primary progressive multiple sclerosis and relapsing multiple sclerosis with a twice-yearly dosing regimen that patients are likely to prefer over alternatives that typically involve monthly injections or daily doses, Roche officials said

A Darlington grandad is leading a North East trial to assess the part Virtual Reality can play in the treatment of Parkinson’s Disease.

Physician scientists at The Ohio State University Wexner Medical Center and College of Medicine are studying why multiple sclerosis (MS) worsens as patients gro

Genetic evolution offers insights into American medicine—along with a warning about what can happen when healthcare systems fail to change.

<p>Optic neuritis occurs because of swelling in or around the optic nerve. For those with MS-related optic neuritis, the swelling subsides on its own, and vision usually recovers. For many people whose optic neuritis does not result from MS, the optic nerve can be permanently damaged unless high doses of steroids are given quickly, resulting in loss of sight. However, steroids can result in harmful side effects. When people first develop optic neuritis, it can be difficult for patients and...

The multiple sclerosis support group meets on the first Tuesday of every month and has guest experts who discuss a variety of topics related to MS and its symptoms.